# EPAT: Estrogen in the Prevention of Atherosclerosis Trial

> **NCT00115024** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute on Aging (NIA)** · enrollment: 222 (—)

## Conditions studied

- Atherosclerosis
- Postmenopause

## Interventions

- **DRUG:** Micronized 17B-estradiol

## Key facts

- **NCT ID:** NCT00115024
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-04
- **Primary completion:** 1998-11
- **Final completion:** 1998-11
- **Target enrollment:** 222 (—)
- **Last updated:** 2009-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115024, "EPAT: Estrogen in the Prevention of Atherosclerosis Trial". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00115024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*